Potential New Standard for High-Risk, Pediatric B-Cell Lymphoma

(MedPage Today) -- Adding rituximab (Rituxan) to standard lymphomes malins B (LMB) chemotherapy in children and adolescents with high-risk, mature B-cell lymphoma significantly improved event-free and overall survival, an international phase III...